Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Gerstein

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
JAMA|July 31, 2001
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individualsH C Gerstein, J F Mann, Q Yi, et al.
Lancet (London, England)|September 26, 2006
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial, H C Gerstein, S Yusuf, et al.
Diabetologia|August 17, 2010
Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART studyH C Gerstein, S Islam, S Anand, et al.
Diabetologia|December 1, 2010
Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes, H C Gerstein, V Mohan, et al.
The Canadian Journal of Cardiology|December 17, 1998
The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE InvestigatorsS S Anand, S Yusuf, V Vuksan, et al.
Diabetologia|November 1, 2011
Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trialZ Punthakee, J Bosch, G Dagenais, et al.
International Journal of Clinical Practice|March 29, 2012
Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort studyM F B Braga, A Casanova, H Teoh, et al.
Diabetes Care|February 13, 2008
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial, G R Dagenais, H C Gerstein, et al.
European Journal of Preventive Cardiology|May 10, 2011
Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort studyS S Anand, G R Dagenais, V Mohan, et al.
International Journal of Obesity (2005)|August 29, 2015
What accounts for ethnic differences in newborn skinfold thickness comparing South Asians and White Caucasians? Findings from the START and FAMILY Birth CohortsS S Anand, M K Gupta, K M Schulze, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
JAMA|July 31, 2001
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individualsH C Gerstein, J F Mann, Q Yi, et al.
Lancet (London, England)|September 26, 2006
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial, H C Gerstein, S Yusuf, et al.
Diabetologia|August 17, 2010
Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART studyH C Gerstein, S Islam, S Anand, et al.
Diabetologia|December 1, 2010
Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes, H C Gerstein, V Mohan, et al.
The Canadian Journal of Cardiology|December 17, 1998
The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE InvestigatorsS S Anand, S Yusuf, V Vuksan, et al.
Diabetologia|November 1, 2011
Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trialZ Punthakee, J Bosch, G Dagenais, et al.
International Journal of Clinical Practice|March 29, 2012
Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort studyM F B Braga, A Casanova, H Teoh, et al.
Diabetes Care|February 13, 2008
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial, G R Dagenais, H C Gerstein, et al.
European Journal of Preventive Cardiology|May 10, 2011
Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort studyS S Anand, G R Dagenais, V Mohan, et al.
International Journal of Obesity (2005)|August 29, 2015
What accounts for ethnic differences in newborn skinfold thickness comparing South Asians and White Caucasians? Findings from the START and FAMILY Birth CohortsS S Anand, M K Gupta, K M Schulze, et al.
Pageof 9